Dosimetric comparison of four new design 103Pd brachytherapy sources: Optimal design using silver and copper rod cores

被引:7
作者
Hosseini, S. Hamed [1 ]
Sadeghi, Mahdi [1 ]
Ataeinia, Vahideh [1 ]
机构
[1] Nucl Sci & Technol Res Inst, Agr Med & Ind Res Sch, Tehran 09821, Iran
关键词
brachytherapy; copper; dosimetry; Monte Carlo methods; silver; MONTE-CARLO CALCULATIONS; PARAMETERS; I-125; SEEDS;
D O I
10.1118/1.3151808
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Four new brachytherapy sources, IRA1-Pd-103, IRA2-Pd-103, IRA3-Pd-103, and IRA4-Pd-103, have been developed at Agricultural, Medical, and Industrial Research School and are designed for permanent implant application. With the goal of determining an optimal design for a Pd-103 source, this article compares the dosimetric properties of these sources with reference to the authors' earlier IRA-Pd-103 source. The four new sources differ in end cap configuration and thickness and in the core material, silver or copper, that carries the adsorbed Pd-103. Dosimetric data derived from the authors' Monte Carlo simulation results are reported in accordance with the updated AAPM Task Group No. 43 report (TG-43U1). For each source, the authors obtained detailed results for the dose rate constant Lambda, the radial dose function g(r), the anisotropy function F(r,theta), and the anisotropy factor phi(an)(r). In this study, the optimal source IRA3-Pd-103 provides the most isotropic dose distribution in water with the dose rate constant of 0.678(+/- 0.1%) cGy h(-1) U-1. The IRA3-Pd-103 design has a silver rod core combined with thin-wall, concave end caps. Finally, the authors compared the results for their optimal source with published results for those of other source manufacturers.
引用
收藏
页码:3080 / 3085
页数:6
相关论文
共 18 条
[1]  
Briesmeister J.F., 2000, MCNP-A general Monte Carlo N -particle transport code, version 4A, V2
[2]   Comparison of I-125 sources used for permanent interstitial implants [J].
Heintz, BH ;
Wallace, RE ;
Hevezi, JM .
MEDICAL PHYSICS, 2001, 28 (04) :671-682
[3]   Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source [J].
Li, ZF ;
Palta, JR ;
Fan, JJ .
MEDICAL PHYSICS, 2000, 27 (05) :1108-1112
[4]   Dosimetric characteristics of the InterSource103 palladium brachytherapy source [J].
Meigooni, AS ;
Sowards, K ;
Soldano, M .
MEDICAL PHYSICS, 2000, 27 (05) :1093-1100
[5]   Dosimetric characteristics of the Best® double-wall 103Pd brachytherapy source [J].
Meigooni, AS ;
Bharucha, Z ;
Yoe-Sein, M ;
Sowards, K .
MEDICAL PHYSICS, 2001, 28 (12) :2568-2575
[6]   Measurement of dose-rate constant for 103Pd seeds with air kerma strength calibration based upon a primary national standard [J].
Nath, R ;
Yue, N ;
Shahnazi, K ;
Bongiorni, PJ .
MEDICAL PHYSICS, 2000, 27 (04) :655-658
[7]   DOSIMETRY OF INTERSTITIAL BRACHYTHERAPY SOURCES - RECOMMENDATIONS OF THE AAPM RADIATION-THERAPY COMMITTEE TASK GROUP NO 43 [J].
NATH, R ;
ANDERSON, LL ;
LUXTON, G ;
WEAVER, KA ;
WILLIAMSON, JF ;
MEIGOONI, AS .
MEDICAL PHYSICS, 1995, 22 (02) :209-234
[8]   Dosimetric characteristics of the Pharma Seed™ model BT-125-I source [J].
Popescu, CC ;
Wise, J ;
Sowards, K ;
Meigooni, AS ;
Ibbott, GS .
MEDICAL PHYSICS, 2000, 27 (09) :2174-2181
[9]   12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer [J].
Potters, L ;
Morgenstern, C ;
Calugaru, E ;
Fearn, P ;
Jassal, A ;
Presser, J ;
Mullen, E .
JOURNAL OF UROLOGY, 2005, 173 (05) :1562-1566
[10]   Brachytherapy dosimetry parameters calculated for a new 103Pd source [J].
Rivard, MJ ;
Melhus, CS ;
Kirk, BL .
MEDICAL PHYSICS, 2004, 31 (09) :2466-2470